CHICAGO, IL — A small, single-center analysis suggests that it may be time to increase the recommended maximum, weight-based unfractionated-heparin bolus and infusion doses for patients with ACS so as ...

In 1988, Wheeler et al. [8] reported that physicians treating patients for pulmonary embolism and deep-vein thrombosis frequently underdosed their patients and were slow to change their heparin ...

Treatment with the direct thrombin inhibitor bivalirudin, as compared with heparin plus glycoprotein IIb/IIIa inhibitors, results in similar suppression of ischemia while reducing hemorrhagic ...

The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to ...

Heparin-induced thrombocytopenia (HIT) is a clinicopathologic syndrome in which one or more clinical events, usually thrombocytopenia or thrombosis, are temporally related to heparin administration ...

CHICAGO -- Periprocedural anticoagulation with bivalirudin (Angiomax) for a radial-first approach to primary percutaneous coronary intervention (PCI) improved mortality and bleeding risk compared with ...

Despite its limitations, unfractionated heparin has been the standard anticoagulant used during percutaneous coronary intervention (PCI). Several small studies have suggested that intravenous ...

CHICAGO, IL—(UPDATED) Most cath labs have abandoned bivalirudin during primary PCI in the wake of multiple trials showing no advantages over heparin, but investigators for the BRIGHT-4 study say that ...

Giving IV aspirin and/or unfractionated heparin during endovascular stroke treatment does not seem to be a good idea, at least at the doses evaluated in the MR CLEAN-MED trial. In the study, such ...

Although UFH has been the mainstay therapy for extracorporeal anticoagulation for many decades, low-molecular-weight heparins (LMWHs) have now replaced UFH as the anticoagulant of choice in many ...

CHICAGO (Reuters) - Baxter International Inc on Monday said it has temporarily stopped making the blood-thinner heparin in multi-dose vials after four patients who took the drug died and hundreds of ...